Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Nov 27;10(4):e001664.
doi: 10.1136/tsaco-2024-001664. eCollection 2025.

Concomitant antithrombotic therapy and substance use in older adult trauma patients: a secondary evaluation of an EAST Multicenter Trial

Abby Sheffield  1 , Arnav Mahajan  2   3 , Sharven Taghavi  4 , Danielle Tatum  5 , Marie L Crandall  2 , Brian K Yorkgitis  6 ; EAST Multicenter Prospective Observational Study of Trauma Patients on Antithrombotic Agents Group
Collaborators, Affiliations

Concomitant antithrombotic therapy and substance use in older adult trauma patients: a secondary evaluation of an EAST Multicenter Trial

Abby Sheffield et al. Trauma Surg Acute Care Open. .

Abstract

Background: The concurrent use of antithrombotic agents and intoxicants in older trauma patients (≥65) poses a potential risk for adverse outcomes. As the prevalence of substance use among older adults rises, understanding the impact of these combined factors on trauma outcomes is crucial. This study evaluates the impact of combined intoxication and antithrombotic use on trauma outcomes in older adults.

Methods: We conducted a secondary analysis of data from an Eastern Association for the Surgery of Trauma-sponsored multicenter prospective observational study involving 15 Level I and II trauma centers from February 2018 to June 2019. Included patients were on antithrombotic therapy and had blood alcohol concentration (BAC) and/or urine toxicology (UT) samples collected at trauma evaluation. Intoxication was defined as BAC >0.08 mg/dL or a positive UT. Patient demographics, injury characteristics, and outcomes were analyzed using linear and logistic regression models.

Results: Of 2793 trauma patients on antithrombotics, 862 met inclusion criteria, with 155 (18.0%) testing positive for intoxicants. Positive tests were associated with younger age (74 years vs 79 years, p<0.001), lower Charlson Comorbidity Index (4 vs 5, p<0.001), and similar Injury Severity Scores (6 vs 9, p=0.38). Patients with positive tests had more penetrating mechanisms of injury (11.0% vs 3.7%, p=0.01) and similar hospital stays (3 days vs 4 days, p=0.311). ICU admission rates were lower (32.9% vs 42.2%, p=0.041), with no difference in ICU length of stay or mortality. Higher ICU admissions (p=0.039) and increased ICU stays were seen in those on two substances (OR: 5.26, 95% CI 0.76 to 9.76, p=0.022).

Conclusions: Older trauma patients on antithrombotic therapy with concurrent intoxicant use did not exhibit worse clinical outcomes, despite higher rates of penetrating injuries and polysubstance use. These findings underscore the importance of tailored discharge planning and comprehensive care strategies for this vulnerable population.

Level of evidence: Level III, prognostic/epidemiological.

Keywords: Anticoagulants; Substance-Related Disorders; geriatrics.

PubMed Disclaimer

Conflict of interest statement

None declared.

References

    1. Emigh B, Kobayashi L, Kopp M, Daley M, Teal L, Haan J, Burlew CC, Nirula R, Moore F, Burruss S, et al. The AAST prospective observational multicenter study of the initial experience with reversal of direct oral anticoagulants in trauma patients. Am J Surg. 2021;222:264–9. doi: 10.1016/j.amjsurg.2020.12.034. - DOI - PubMed
    1. Zeeshan M, Jehan F, O’Keeffe T, Khan M, Zakaria ER, Hamidi M, Gries L, Kulvatunyou N, Joseph B. The novel oral anticoagulants (NOACs) have worse outcomes compared with warfarin in patients with intracranial hemorrhage after TBI. J Trauma Acute Care Surg. 2018;85:915–20. doi: 10.1097/TA.0000000000001995. - DOI - PubMed
    1. García-Rodríguez LA, Gaist D, Morton J, Cookson C, González-Pérez A. Antithrombotic drugs and risk of hemorrhagic stroke in the general population. Neurology (ECronicon) 2013;81:566–74. doi: 10.1212/WNL.0b013e31829e6ffa. - DOI - PubMed
    1. Gulati S, Solheim O, Carlsen SM, Øie LR, Jensberg H, Gulati AM, Madsbu MA, Giannadakis C, Jakola AS, Salvesen Ø. Risk of intracranial hemorrhage (RICH) in users of oral antithrombotic drugs: Nationwide pharmacoepidemiological study. PLoS One. 2018;13:e0202575. doi: 10.1371/journal.pone.0202575. - DOI - PMC - PubMed
    1. Dossett LA, Riesel JN, Griffin MR, Cotton BA. Prevalence and implications of preinjury warfarin use: an analysis of the National Trauma Databank. Arch Surg. 2011;146:565–70. doi: 10.1001/archsurg.2010.313. - DOI - PubMed

LinkOut - more resources